Li Jin, Zhong Liping, Wang Fengzhong, Zhu Haibo
Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China.
Life Science College of Tarim University, Xinjiang 843300, China.
Acta Pharm Sin B. 2017 May;7(3):249-259. doi: 10.1016/j.apsb.2016.12.003. Epub 2017 Mar 3.
AMP-activated protein kinase (AMPK), known as a sensor and a master of cellular energy balance, integrates various regulatory signals including anabolic and catabolic metabolic processes. Accompanying the application of genetic methods and a plethora of AMPK agonists, rapid progress has identified AMPK as an attractive therapeutic target for several human diseases, such as cancer, type 2 diabetes, atherosclerosis, myocardial ischemia/reperfusion injury and neurodegenerative disease. The role of AMPK in metabolic and energetic modulation both at the intracellular and whole body levels has been reviewed elsewhere. In the present review, we summarize and update the paradoxical role of AMPK implicated in the diseases mentioned above and put forward the challenge encountered. Thus it will be expected to provide important clues for exploring rational methods of intervention in human diseases.
AMP激活的蛋白激酶(AMPK),作为细胞能量平衡的传感器和主宰,整合包括合成代谢和分解代谢过程在内的各种调节信号。随着基因方法和大量AMPK激动剂的应用,快速进展已将AMPK确定为几种人类疾病(如癌症、2型糖尿病、动脉粥样硬化、心肌缺血/再灌注损伤和神经退行性疾病)有吸引力的治疗靶点。AMPK在细胞内和全身水平的代谢和能量调节中的作用已在其他地方进行了综述。在本综述中,我们总结并更新了AMPK在上述疾病中所涉及的矛盾作用,并提出了所遇到的挑战。因此,有望为探索合理的人类疾病干预方法提供重要线索。